Anticoagulation for coexisting bioprosthetic aortic valve thrombosis and anticoagulant-related bleeding: "A double edge sword".
Jiaqian XuAdrian L LataLi ZhouBharathi UpadhyaMin PuPublished in: Echocardiography (Mount Kisco, N.Y.) (2020)
The choice of anticoagulant agents for newly implanted bioprosthetic valve varies significantly, particularly in the presence of postoperative atrial fibrillation with increasing use of nonvitamin K oral anticoagulation (NOACs) in recent years. We reported a challenging case with a coexisting bioprosthetic aortic valve thrombosis and significant anticoagulant-related bleeding. Clinical management strategy and brief literature review were presented.
Keyphrases
- aortic valve
- atrial fibrillation
- oral anticoagulants
- aortic valve replacement
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- aortic stenosis
- catheter ablation
- left atrial
- left atrial appendage
- direct oral anticoagulants
- pulmonary embolism
- heart failure
- venous thromboembolism
- percutaneous coronary intervention
- patients undergoing
- case report
- mitral valve
- left ventricular
- acute coronary syndrome
- ejection fraction